Live Sessions
Recorded Sessions

Programme at a glance

Programme at a glance, Virtual

CEST (Central European summer time)

Thursday, 26 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
14.00 - 17.50
Channel 1
SCIENTIFIC SESSION I
Chairpersons: ‣ Cyrus Cooper, ‣ Nicholas Harvey
14.00
Channel 1
ROS-IOF-ESCEO Symposium
‣ Royal Osteoporosis Society’s Osteoporosis and Bone Research Academy – Our journey towards a cure
Chairpersons: ‣ Cyrus Cooper, ‣ Neil Gittoes
‣ Royal Osteoporosis Society Research Roadmap: the patient perspective
‣ An introduction to the Royal Osteoporosis Society’s Osteoporosis and Bone Research Academy Juliet Compston
‣ The Research Road Map: Our journey towards a cure Nicholas Harvey
‣ Exploring the research priorities : Causes and mechanisms Stuart Ralston
‣ Exploring the research priorities : Optimising effectiveness of assessments and treatment Eugene McCloskey
‣ Exploring the research priorities : Novel technologies for skeletal assessment Emma Clark
‣ Q&A session
15.30
Channel 1
Opening of the Congress
‣ Cyrus Cooper
15.40
Channel 1
Plenary Lecture 1
‣ Management of musculoskeletal disease from cradle to grave Cyrus Cooper
16.10
Channel 1
Guest lecture
‣ Feast or Famine: How Nutrient Intake Regulates Bone Remodeling Cliff Rosen
16.40
Channel 1
Presentation of prizes and awards
‣ Presentation of the IOF Olof Johnell Science Award, the IOF President’s Award and the ESCEO-IOF Herbert Fleisch Medal Cyrus Cooper
‣ Presentation of the IOF Medal of Achievement Nicholas Harvey
17.50 - 19.30
Channel 1
SCIENTIFIC SESSION II
Chairpersons: ‣ John A. Kanis, ‣ René Rizzoli
17.50
Channel 1
Plenary Lecture 2
‣ Building bone strength with anabolic agents Michael R. McClung
18.20
Channel 1
Best clinical papers published in 2020
‣ René Rizzoli
19.00
Channel 1
Meet-The-Expert Session
‣ Transgender medicine, bone and muscle Jean‑Marc Kaufman
19.30
Channel 1
Adjournement
Friday, 27 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
09.00 - 11.50
Channel 1
SCIENTIFIC SESSION III
Chairpersons: ‣ Jean‑Yves Reginster, ‣ Manju Chandran
09.00
Channel 1
Plenary Lecture 3
‣ Management of bone disease in cancer Robert E. Coleman
09.30
Channel 1
Plenary Lecture 4
‣ Thyroid, bone and cartilage Graham Williams
10.00
Channel 1
Meet-The-Expert Session
‣ Impact of glucocorticoids on bone and muscle Evelien Gielen
10.30
Channel 1
Oral communication selected from abstracts
‣ OC1 - RECENT SENTINEL FRACTURES AND SUBSEQUENT FRACTURE PROBABILITIES OVER TWO, FIVE AND 10-YEAR TIMEFRAMES
Presenting author: ‣ H. Johansson
Authors: ‣ E. V. McCloskey, ‣ N. C. Harvey, ‣ V. Gudnason, ‣ G. Sigurdsson, ‣ K. Siggeirsdottir, ‣ M. Lorentzon, ‣ E. Liu, ‣ L. Vandenput, ‣ W. D. Leslie, ‣ J. A. Kanis
10.40
Channel 1
Meet-The-Expert Session
‣ HIV and bone Emmanuel Biver
11.10
Channel 1
Oral communication selected from abstracts
‣ OC2 - ASSOCIATIONS BETWEEN BONE AND VASCULAR HEALTH IN THE UK BIOBANK
Presenting author: ‣ Z. Raisi‑Estabragh
Authors: ‣ L. Biasiolli, ‣ J. Cooper, ‣ N. Aung, ‣ K. Fung, ‣ J. Paiva, ‣ M. Sanghvi, ‣ R. Thomson, ‣ E. M.  Curtis, ‣ J. Paccou, ‣ J. Rayner, ‣ K. Werys, ‣ H. Puchta, ‣ K. Thomas, ‣ A. M. Lee, ‣ S. Piechnik, ‣ S. Neubauer, ‣ P. B.  Munroe, ‣ C. Cooper, ‣ S. E. Petersen, ‣ N. C. Harvey
11.20
Channel 1
Plenary Lecture 5
‣ Bone and cartilage talk together Ali Mobasheri
11.50 - 12.00
Channel 1
BREAK 10'
13.30 - 15.20
Channel 1
SCIENTIFIC SESSION IV
Chairpersons: ‣ Evelien Gielen, ‣ Radmila Matijevic
13.30
Channel 1
Plenary Lecture 6
‣ Are there treatments for sarcopenia? Marjolein Visser
14.00
Channel 1
Meet-The-Expert Session
‣ Is screening for osteoporosis useful? E. M. Curtis
14.30
Channel 1
Oral communication selected from abstracts
‣ OC3 - A MULTICENTER, OBSERVATIONAL, EXTENSION STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF A SINGLE LORECIVIVINT INJECTION IN KNEE OA SUBJECTS
Presenting author: ‣ J. Tambiah
Authors: ‣ I. Simsek, ‣ C. Swearingen, ‣ H. Ghandehari, ‣ S. Kennedy, ‣ N. Skrepnik, ‣ Y. Yazici
14.40
Channel 1
Meet-The-Expert Session
‣ Calcium-vitamin D, still a role in osteoporosis management? Elaine M. Dennison
15.10
Channel 1
Oral communication selected from abstracts
‣ OC4 - FRACTURE RISK IN PARKINSON'S DISEASE: DRIVEN BY LOW BONE STRENGTH, MUSCLE WEAKNESS OR FALLS?
Presenting author: ‣ P. Bhattia
Authors: ‣ E. V. McCloskey, ‣ H. Shreef, ‣ H. Johansson, ‣ M. Lorentzon, ‣ N. C. Harvey, ‣ J. A. Kanis
15.20 - 15.30
Channel 1
BREAK 10'
15.30 - 16.55
Channel 1
SCIENTIFIC SESSION V
Chairpersons: ‣ Claudia Campusano, ‣ Maria Luisa Brandi
15.30
Channel 1
Plenary Lecture 7
‣ Gut microbiome, bone and joint Georg Schett
16.00
Channel 1
Meet-The-Expert Session
‣ Rehabilitation after fragility fracture Olivier Bruyère
16.30
Channel 1
Oral communication selected from abstracts
‣ OC5 - PREVALENCE AND AGREEMENT BETWEEN RECENT SARCOPENIA DEFINITIONS: FINDINGS FROM FOUR POPULATION-BASED COHORTS
Presenting author: ‣ L. D. Westbury
Authors: ‣ H. E. Syddall, ‣ J. A. Cauley, ‣ P. M. Cawthon, ‣ E. M.  Curtis, ‣ K. Ensrud, ‣ R. A. Fielding, ‣ H. Johansson, ‣ J. A. Kanis, ‣ M. K. Karlsson, ‣ T. Kwok, ‣ N. Lane, ‣ M. Lorentzon, ‣ D. Mellström, ‣ A. B.  Newman, ‣ C. Ohlsson, ‣ E. Orwoll, ‣ E. Ribom, ‣ B. E. Rosengren, ‣ J. T. Schousboe, ‣ E. J. Shiroma, ‣ N. C. Harvey, ‣ E. M. Dennison, ‣ C. Cooper
16.40
Channel 1
Presentation of prizes and awards
‣ Presentation of the 2020 ESCEO Medal of Excellence, the IOF CNS Medal, the ESCEO-IOF Pierre Meunier Young Scientist Award and the ESCEO-IOF Young Investigator Awards Jean‑Yves Reginster
‣ Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards Jean‑Yves Reginster, James Howe
16.55 - 17.00
Channel 1
BREAK 05'
18.30
Channel 1
Adjournement
Saturday, 28 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
09.30 - 11.20
Channel 1
SCIENTIFIC SESSION VI
Chairpersons: ‣ Charlotte Beaudart, ‣ Stefania Maggi
09.30
Channel 1
Plenary Lecture 8
‣ Is genetics helping to improve osteoporosis management ? Emma Duncan
10.00
Channel 1
Meet-The-Expert Session
‣ Fracture during childhood and adolescence Kate Ward
10.30
Channel 1
Oral communication selected from abstracts
‣ OC9 - MAINTENANCE OF EFFECT OF BUROSUMAB TREATMENT AND THE IMPACT OF TREATMENT INTERRUPTION ACROSS A 96-WEEK PHASE 3 STUDY AND 48 WEEKS OF A PHASE 3B STUDY IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA (XLH)
Presenting author: ‣ P. Kamenicky
Authors: ‣ K. Briot, ‣ M. L. Brandi, ‣ M. Cohen‑Solal, ‣ R. Crowley, ‣ R. Keen, ‣ S. Kolta, ‣ R. Lachmann, ‣ S. Ralston, ‣ J. Walsh, ‣ A. Rylands, ‣ A. Williams, ‣ W. Sun, ‣ A. Nixon, ‣ M. Nixon, ‣ K. Javaid
10.40
Channel 1
Meet-The-Expert Session
‣ Discussion of complex bone disorder clinical cases Nicholas R. Fuggle and Roland Chapurlat
11.10
Channel 1
Oral communication selected from abstracts
‣ OC14 - PARATHYROIDECTOMY IS ASSOCIATED WITH REDUCED RISK OF FRACTURE AND CARDIOVASCULAR EVENTS IN PATIENTS DIAGNOSED WITH PRIMARY HYPERPARATHYROIDISM - A NATIONAL, RETROSPECTIVE COHORT STUDY
Presenting author: ‣ M. Lorentzon
Authors: ‣ K. F. Axelsson, ‣ M. Wallander, ‣ H. Johansson, ‣ N. C. Harvey, ‣ L. Vandenput, ‣ E. V. McCloskey, ‣ L. Enwu, ‣ J. A. Kanis, ‣ H. Litsne
09.30 - 11.20
Channel 2
SCIENTIFIC SESSION VII
Chairpersons: ‣ Friederike Thomasius, ‣ Etienne Cavalier
09.30
Channel 2
Oral communication selected from abstracts
‣ OC6 - GLUCOSAMINE SULPHATE: AN UMBRELLA REVIEW OF HEALTH OUTCOMES
Presenting author: ‣ N. Veronese
Authors: ‣ J. Demurtas, ‣ L. Smith, ‣ J.‑Y. Reginster, ‣ O. Bruyère, ‣ G. Honvo, ‣ S. Maggi
09.40
Channel 2
Oral communication selected from abstracts
‣ OC7 - THE ASSOCIATIONS BETWEEN DISEASE MODIFYING ANTIRHEUMATIC DRUGS AND INCIDENT AS WELL A PROGRESSION OF RADIOGRAPHIC HAND OSTEOARTHRITIS IN RHEUMATOID ARTHRITIS PATIENTS
Presenting author: ‣ T. Burkard
Authors: ‣ C. Lechtenboehmer, ‣ S. Reichenback, ‣ U. A. Walker, ‣ A. M. BURDEN, ‣ T. Hügle
09.50
Channel 2
Oral communication selected from abstracts
‣ OC8 - MEANINGFUL IMPROVEMENTS IN WOMAC PAIN AND PHYSICAL FUNCTION IN THREE PHASE 3 TRIALS OF TANEZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE OSTEOARTHRITIS: A RESPONDER ANALYSIS
Presenting author: ‣ P. Conaghan
Authors: ‣ R. H. Dworkin, ‣ T. J. Schnitzer, ‣ F. Berenbaum, ‣ R. Yang, ‣ A. G. Bushmakin, ‣ J. C. Cappelleri, ‣ M. T. Brown, ‣ L. Viktrup, ‣ L. Abraham
10.00
Channel 2
Meet-The-Expert Session
‣ Lyosis Software - A new way to manage FLS centers more efficiently and cost optimized Werner Fehn
10.30
Channel 2
Oral communication selected from abstracts
‣ OC10 - ROMOSOZUMAB EFFICACY AND SAFETY IN EUROPEAN PATIENTS: A SUBANALYSIS OF THE PHASE 3, RANDOMISED FRAME STUDY
Presenting author: ‣ B. Langdahl
Authors: ‣ L. C. Hofbauer, ‣ S. Ferrari, ‣ Z. Wang, ‣ A. Fahrleitner‑Pammer, ‣ E. Gielen, ‣ P. Lakatos, ‣ E. Czerwinski, ‣ E. Jodar‑Gimeno, ‣ J. Timoshanko, ‣ M. Oates, ‣ C. Libanati
10.40
Channel 2
Oral communication selected from abstracts
‣ OC11 - MULTIDIMENSIONAL PROGNOSTIC INDEX AND THE RISK OF FRACTURES: AN 8-YEAR LONGITUDINAL COHORT STUDY IN THE OSTEOARTHRITIS INITIATIVE
Presenting author: ‣ N. Veronese
Authors: ‣ L. Smith, ‣ E. Zigoura, ‣ M. Barbagallo, ‣ L. Dominguez, ‣ C. Cooper, ‣ R. Rizzoli, ‣ J.‑Y. Reginster, ‣ S. Maggi, ‣ A. Pilotto
10.50
Channel 2
Oral communication selected from abstracts
‣ OC12 - THE PREVALENCE OF COMMUNITY-DWELLING OLDER ADULTS AT HIGH FRACTURE RISK WHO ARE NOT TAKING OSTEOPOROSIS MEDICATIONS: RESULTS FROM THE CANADIAN LONGITUDINAL STUDY ON AGING (CLSA)
Presenting author: ‣ C. McArthur
Authors: ‣ A. Lee, ‣ H. Abu Alrob, ‣ J. D. Adachi, ‣ L. Giangregorio, ‣ L. Griffith, ‣ S. N. Morin, ‣ L. Thabane, ‣ G. Ioannidis, ‣ J. Lee, ‣ W. D. Leslie, ‣ A. Papaioannou
11.00
Channel 2
Oral communication selected from abstracts
‣ OC13 - PATIENT'S PREFERENCES FOR LIFESTYLE CHANGES IN OSTEOPOROTIC FRACTURE PREVENTION: A CROSS-EUROPEAN DISCRETE-CHOICE EXPERIMENT
Presenting author: ‣ C. Beaudart
Authors: ‣ A. Boonen, ‣ N. Li, ‣ S. Bours, ‣ S. Goemaere, ‣ J.‑Y. Reginster, ‣ C. Roux, ‣ B. MCGOWAN, ‣ A. Diez‑Perez, ‣ R. Rizzoli, ‣ C. Cooper, ‣ M. Hiligsmann
11.10
Channel 2
Oral communication selected from abstracts
‣ OC15 - FRAILTY IS ASSOCIATED WITH INFLAMMATION AND REDUCED BONE MINERAL DENSITY INDEPENDENT OF FAT MASS: FINDINGS FROM UK BIOBANK
Presenting author: ‣ E. M.  Curtis
Authors: ‣ S. D'angelo, ‣ S. Woolford, ‣ R. Durdin, ‣ Z. Raisi‑Estabragh, ‣ K. A. Ward, ‣ C. Cooper, ‣ N. C. Harvey
11.20 - 13.20
Channel 1
SCIENTIFIC SESSION VIII
Chairpersons: ‣ Gemma Adib, ‣ Mickaël Hiligsmann
11.20
Channel 1
Meet-The-Expert Session
‣ Can we influence fracture repair? Julio Fernandes
11.50
Channel 1
Oral communication selected from abstracts
‣ OC18 - LOCAL OSTEO-ENHANCEMENT PROCEDURE SIGNIFICANTLY INCREASES BONE MINERAL DENSITY IN THE PROXIMAL FEMUR OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK FOR HIP FRACTURE
Presenting author: ‣ De Schepper
Authors: ‣ J. Howe, ‣ J. Shaul, ‣ J. Coteur, ‣ B. Huber
12.00
Channel 1
Meet-The-Expert Session
‣ FLS and fracture risk reduction Kassim Javaid
12.30
Channel 1
Oral communication selected from abstracts
‣ OC23 - QUALITY OF LIFE, RESOURCE USE AND COSTS RELATED TO FRAGILITY FRACTURES: DEVELOPMENT AND EVALUATION OF MULTIDISCIPLINARY POST-FRACTURE CARE PATHWAYS
Presenting author: ‣ J. Talevski
Authors: ‣ K. Sanders, ‣ J. Watts, ‣ L. Busija, ‣ A. Beauchamp, ‣ G. Duque, ‣ F. Borgström, ‣ J. A. Kanis, ‣ A. Svedbom, ‣ A. Stuart, ‣ S. Brennan‑Olsen
12.40
Channel 1
Meet-The-Expert Session
‣ How to warrant reliable data for calciotropic hormones and bone turnover markers assays Etienne Cavalier
13.10
Channel 1
Oral communication selected from abstracts
‣ OC29 - CORTICAL PORE SIZE DISTRIBUTION AND VISCOELASTIC HUMAN TIBIA PROPERTIES DISCRIMINATE FRAGILITY FRACTURES INDEPENDENT OF BONE MINERAL DENSITY
Presenting author: ‣ K. Raum
Authors: ‣ G. Armbrecht, ‣ H. Minh Nguyen, ‣ J. Massmann
13.20
BREAK 40'
11.20 - 14.30
Channel 2
SCIENTIFIC SESSION IX
Chairpersons: ‣ Helena Johansson, ‣ Emmanuel Biver
11.20
Channel 2
Oral communication selected from abstracts
‣ OC16 - EPIGENETIC AGE ACCELERATION ASSOCIATIONS WITH SKELETAL OUTCOMES: DIFFERENTIAL IMPACTS IN MEN AND WOMEN
Presenting author: ‣ N. R. Fuggle
Authors: ‣ M. A. Clynes, ‣ M. O’breasail, ‣ C. Parsons, ‣ J. W. Holloway, ‣ A. Kitaba, ‣ K. A. Ward, ‣ C. Cooper, ‣ E. M. Dennison
11.30
Channel 2
Oral communication selected from abstracts
‣ OC17 - COMPARISON OF FRACTURE RATES AND ECONOMIC OUTCOMES BETWEEN WOMEN WITH OSTEOPOROSIS RECEIVING RISEDRONATE GASTRO-RESISTANT (GR) AND ALENDRONATE
Presenting author: ‣ F. Thomasius
Authors: ‣ S. Palacios, ‣ A. Alam, ‣ M. Boolell, ‣ F. Vekeman, ‣ G. Gauthier
11.40
Channel 2
Oral communication selected from abstracts
‣ OC19 - A PROSPECTIVE OPEN-LABEL OBSERVATIONAL STUDY OF A BUFFERED SOLUBLE 70 MG ALENDRONATE EFFERVESCENT TABLET ON UPPER GASTROINTESTINAL SAFETY AND MEDICATION ERRORS: THE GASTROPASS STUDY
Presenting author: ‣ S. Minisola
Authors: ‣ A. Ponce Vargas, ‣ G. Letizia Mauro, ‣ F. Bonet Madurga, ‣ G. Adami, ‣ D. M. Black, ‣ N. Qizilbash, ‣ J. Blanch Rubió
11.50
Channel 2
Oral communication selected from abstracts
‣ OC20 - OSTEOCALCIN, MUSCLE FUNCTION AND 15-YEAR FALLS-RELATED HOSPITALISATIONS IN OLDER WOMEN: THE PERTH LONGITUDINAL STUDY OF AGEING WOMEN
Presenting author: ‣ C. Smith
Authors: ‣ J. R. Lewis, ‣ M. Sim, ‣ W. H. Lim, ‣ E. M. Lim, ‣ L. C. Blekkenhorst, ‣ T. Brennan‑Speranza, ‣ L. Adams, ‣ E. Byrnes, ‣ G. Duque, ‣ I. Levinger, ‣ R. Prince
12.00
Channel 2
Oral communication selected from abstracts
‣ OC21 - RELATIONSHIPS BETWEEN MALNUTRITION, SARCOPENIA, AND FRAILTY AND THE INCIDENCE OF COVID-19 IN OLDER ADULTS: DATA FROM THE SARCOPHAGE COHORT
Presenting author: ‣ L. Lengelé
Authors: ‣ M. Locquet, ‣ M. Moutschen, ‣ C. Beaudart, ‣ J.‑F. Kaux, ‣ S. Gillain, ‣ C. Shadouh, ‣ J.‑Y. Reginster, ‣ O. Bruyère
12.10
Channel 2
Oral communication selected from abstracts
‣ OC22 - FUNCTIONAL BRAIN PROCESSES IN SARCOPENIA - EVIDENCE FOR DIFFERENTIAL CENTRAL NEURAL MECHANISMS IN DYNAPENIC OLDER ADULTS
Presenting author: ‣ W. Trost
Authors: ‣ A. Trombetti, ‣ M. Hars, ‣ N. Fernandez, ‣ F. Herrmann, ‣ T. Chevalley, ‣ S. Ferrari, ‣ G. Gold, ‣ R. Rizzoli, ‣ P. Vuilleumier
12.20
Channel 2
Oral communication selected from abstracts
‣ OC24 - UC-II® COLLAGEN HELPS SUPPORT KNEE JOINT MOBILITY IN HEALTHY SUBJECTS: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY
Presenting author: ‣ V. Juturu
Authors: ‣ K. Knaub, ‣ W. Alt, ‣ C. Schön, ‣ S. Durkee, ‣ Z. Saiyed
12.30
Channel 2
Oral communication selected from abstracts
‣ OC25 - 10-YEAR TRENDS IN PREVALENCE OF RADIOGRAPHIC HIP OSTEOARTHRITIS IN JAPANESE MEN AND WOMEN: COMPARISON OF BASELINE AND 4TH RESEARCH ON OSTEOARTHRITIS/OSTEOPOROSIS AGAINST DISABILITY STUDY SURVEYS
Presenting author: ‣ T. Iidaka
Authors: ‣ S. Muraki, ‣ H. Oka, ‣ C. Horii, ‣ K. Nakamura, ‣ T. Akune, ‣ S. Tanaka, ‣ N. Yoshimura
12.40
Channel 2
Oral communication selected from abstracts
‣ OC26 - SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF AN INTRA-ARTICULAR CORTICOSTEROID INJECTION ADMINISTERED 7 DAYS BEFORE OR AFTER INTRA-ARTICULAR LORECIVIVINT INJECTION INTO THE SAME KNEE OF HEALTHY VOLUNTEERS: AN OPEN-LABEL, PARALLEL-ARM STUDY
Presenting author: ‣ Y. Yazici
Authors: ‣ A. Halseth, ‣ S. Kennedy, ‣ C. Swearingen, ‣ I. Simsek, ‣ M. Fineman, ‣ N. E. Lane
12.50
Channel 2
Oral communication selected from abstracts
‣ OC27 - EFFECT OF 2 FORMS OF VITAMIN D ON SKELETAL MUSCLE FIBER SIZE AND VITAMIN D RECEPTOR (VDR) CONCENTRATION IN YOUNGER POSTMENOPAUSAL WOMEN
Presenting author: ‣ L. Ceglia
Authors: ‣ D. Rivas, ‣ M. Schlögl, ‣ H. A. Bischoff‑Ferrari, ‣ B. Dawson‑Hughes
13.00
Channel 2
Oral communication selected from abstracts
‣ OC28 - NEUROFILAMENT-LIGHT CHAINS (NF-L), A BIOMARKER OF NEURONAL DAMAGE, IS INCREASED IN SARCOPENIC PATIENTS: RESULTS OF THE SARCOPHAGE STUDY
Presenting author: ‣ A. Ladang
Authors: ‣ S. Kovacs, ‣ L. Lengelé, ‣ M. Locquet, ‣ J.‑Y. Reginster, ‣ O. Bruyère, ‣ E. Cavalier
14.00 - 17.00
Channel 1
SCIENTIFIC SESSION X
Chairpersons: ‣ Elaine M. Dennison, ‣ Bess Dawson‑Hughes
14.00
Channel 1
Meet-The-Expert Session
‣ Management of men with osteoporosis Alberto Ferlin
14.30
Channel 1
Oral communication selected from abstracts
‣ OC30 - IN HEALTHY MEN, EARLY DECLINE IN TRABECULAR BONE MINERAL DENSITY IS, IN PART, RELATED TO DECREASES IN SEX STEROIDS
Presenting author: ‣ T. Banica
Authors: ‣ C. Verroken, ‣ H. Zmierczak, ‣ S. Goemaere, ‣ J.‑M. Kaufman, ‣ B. Lapauw
14.40
Channel 1
Plenary Lecture 9
‣ Rehabilitation of menopausal hormone therapy in osteoporosis management Irene Lambrinoudaki
15.10
Channel 1
Oral communication selected from abstracts
‣ OC31 - MULTICENTER PROSPECTIVE STUDY TO ASSESS EFFICACY AND SAFETY GLYCOSAMINOGLYCAN PEPTIDE COMPLEX IN PATIENTS WITH KNEE OSTEOARTHRITIS AND COMORBIDITY
Presenting author: ‣ E. Taskina
Authors: ‣ N. Kashevarova, ‣ E. Sharapova, ‣ S. Anikin, ‣ E. Strebkova, ‣ K. Telyshev, ‣ L. Alekseeva, ‣ A. Lila, ‣ T. Raskina, ‣ E. Otteva, ‣ E. Zonova, ‣ N. Chichasova, ‣ V. Lila, ‣ I. Vinogradova, ‣ O. Ivanova, ‣ S. Yakupova, ‣ E. Shmidt
15.20
Channel 1
Oral communication selected from abstracts
‣ OC32 - IDENTIFICATION OF PATIENTS AT LOW, HIGH AND VERY HIGH RISK OF OSTEOPOROTIC FRACTURES IN THE UK USING FRAX
Presenting author: ‣ E. V. McCloskey
Authors: ‣ N. C. Harvey, ‣ H. Johansson, ‣ M. Lorentzon, ‣ E. Liu, ‣ L. Vandenput, ‣ J. A. Kanis
15.30
Channel 1
Oral communication selected from abstracts
‣ OC33 - CIRCULATING MICRORNA AS BIOMARKERS OF OSTEOPOROSIS AND FRACTURE RISK
Presenting author: ‣ S. Donati
Authors: ‣ S. Ciuffi, ‣ F. Marini, ‣ A. Botta, ‣ G. Isaia, ‣ P. D'Amelio, ‣ C. Marcocci, ‣ S. Migliaccio, ‣ S. Minisola, ‣ J. Pepe, ‣ R. Nuti, ‣ U. Tarantino, ‣ M. L. Brandi
15.40
Channel 1
Oral communication selected from abstracts
‣ OC34 - PALOVAROTENE FOR THE TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA IN FEMALES AGED ≥8 YEARS AND MALES AGED ≥10 YEARS: DATA FROM THE PHASE III MOVE TRIAL
Presenting author: ‣ G. Baujat
Authors: ‣ R. J. Pignolo, ‣ M. Al Mukaddam, ‣ M. A. Brown, ‣ A. M. Cheung, ‣ C. L. De Cunto, ‣ P. Delai, ‣ E. C. Hsiao, ‣ P. Kannu, ‣ R. Keen, ‣ E. E. Mancilla, ‣ S. K. Berglund, ‣ R. Marino, ‣ A. Strahs, ‣ F. S. Kaplan
15.50
Channel 1
Plenary Lecture 10
‣ New approaches of rare skeletal diseases management Maria Luisa Brandi
17.20
Channel 1
Oral communication selected from abstracts
‣ OC35 - MIGHT NSAID USE INTERACT WITH BISPHOSPHONATE EFFICACY? EXPLORATORY ANALYSIS FROM THE CLODRONATE HIP STUDY
Presenting author: ‣ E. V. McCloskey
Authors: ‣ Z. Zheng, ‣ H. Johansson, ‣ N. C. Harvey, ‣ M. Lorentzon, ‣ J. A. Kanis
17.00
Adjournement